Zoledronate (Aclasta) Infusion Subsidy
Maximum funding cap reached for 2018-19 funding year
Counties Manukau Health provides funding to subsidise zoledronate (aclasta) infusions for eligible patients.
Funding of a maximum of 300 patients is available per year. For the period ending June 2019 this maximum funding allocation has now been reached.
Funding will resume 1st July 2019. Please re-visit this page to apply for funding after this date.
All existing pre-appoved subsidy vouchers will be honoured.